Biosynthesis of chiral 3-hydroxyvalerate from single propionate-unrelated carbon sources in metabolically engineered E. coli

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Microbial Cell Factories (Impact Factor: 4.22). 11/2010; 9(1):96. DOI: 10.1186/1475-2859-9-96
Source: PubMed


The ability to synthesize chiral building block molecules with high optical purity is of considerable importance to the fine chemical and pharmaceutical industries. Production of one such compound, 3-hydroxyvalerate (3HV), has previously been studied with respect to the in vivo or in vitro enzymatic depolymerization of biologically-derived co-polymers of poly(3-hydroxybutyrate-co-3-hydroxyvalerate). However, production of this biopolymeric precursor typically necessitates the supplementation of a secondary carbon source (e.g., propionate) into the culture medium. In addition, previous approaches for producing 3HV have not focused on its enantiopure synthesis, and thus suffer from increased costs for product purification.
Here, we report the selective biosynthesis of each 3HV stereoisomer from a single, renewable carbon source using synthetic metabolic pathways in recombinant strains of Escherichia coli. The product chirality was controlled by utilizing two reductases of opposing stereoselectivity. Improvement of the biosynthetic pathway activity and host background was carried out to elevate both the 3HV titers and 3HV/3HB ratios. Overall, shake-flask titers as high as 0.31 g/L and 0.50 g/L of (S)-3HV and (R)-3HV, respectively, were achieved in glucose-fed cultures, whereas glycerol-fed cultures yielded up to 0.19 g/L and 0.96 g/L of (S)-3HV and (R)-3HV, respectively.
Our work represents the first report of direct microbial production of enantiomerically pure 3HV from a single carbon source. Continued engineering of host strains and pathway enzymes will ultimately lead to more economical production of chiral 3HV.

Download full-text


Available from: Hsien-Chung Tseng, Mar 06, 2014
  • Source
    • "ΔendAΔrecA and the reduced aromatic aldehyde reduction ( " RARE " ) ΔendAΔrecA strains (Kunjapur et al., 2014; Tseng et al., 2010) were used as hosts for experiments testing biosynthesis of C3–C5 alkanes. The fadD gene was deleted in MG1655(DE3) and RARE strains using a donor strain from the Keio collection (Baba et al., 2006) and the method of P1 transduction (Thomason et al., 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Typical renewable liquid fuel alternatives to gasoline are not entirely compatible with current infrastructure. We have engineered Escherichia coli to selectively produce alkanes found in gasoline (propane, butane, pentane, heptane, and nonane) from renewable substrates such as glucose or glycerol. Our modular pathway framework achieves carbon-chain extension by two different mechanisms. A fatty acid synthesis route is used to generate longer chains heptane and nonane, while a more energy efficient alternative, reverse-β-oxidation, is used for synthesis of propane, butane, and pentane. We demonstrate that both upstream (thiolase) and intermediate (thioesterase) reactions can act as control points for chain-length specificity. Specific free fatty acids are subsequently converted to alkanes using a broad-specificity carboxylic acid reductase and a cyanobacterial aldehyde decarbonylase (AD). The selectivity obtained by different module pairings provides a foundation for tuning alkane product distribution for desired fuel properties. Alternate ADs that have greater activity on shorter substrates improve observed alkane titer. However, even in an engineered host strain that significantly reduces endogenous conversion of aldehyde intermediates to alcohol byproducts, AD activity is observed to be limiting for all chain lengths. Given these insights, we discuss guiding principles for pathway selection and potential opportunities for pathway improvement.
    Full-text · Article · Nov 2015 · Metabolic Engineering
  • Source
    • "Besides the use of Ter, butyrate production by E. coli was substantially enhanced by genetically deleting competing native fermentation pathways (Lim et al., 2013) as was previously done for the fermentative production of ethanol (Jarboe et al., 2007) and other bio-based products (Lim et al., 2013; Shen et al., 2011; Zhu et al., 2011). In addition to butyrate production, reactions similar to those described above for the conversion of two molecules of acetyl-CoA to butyryl-CoA together with TesB have been used under aerobic conditions to produce functionalized short-chain carboxylic acids, including 3-hydroxyvalerate (3-hydroxy- pentanoate) (Tseng et al., 2010), dihydroxybutyrate (Martin et al., 2013), 3-hydroxy-4-methylvalerate (Martin et al., 2013) and a variety of alcohols (Tseng & Prather, 2012). Similar to reverse b-oxidation, fermentative pathways proceed by sequential condensation of acetyl-CoA and are more energy efficient than the interruption of phospholipid biosynthesis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Escherichia coli was engineered for the production of even and odd-chain fatty acids (FA) by fermentation. Co-production of thiolase, hydroxybutyryl-CoA dehydrogenase, crotonase and trans-enoyl-CoA reductase from a synthetic operon allowed the production of butyrate, hexanoate, and octanoate. Elimination of native fermentation pathways by genetic deletion (ΔldhA, ΔadhE, ΔackA, Δpta, ΔfrdC) helped to eliminate undesired by-products an increase product yields. Initial butyrate production rates were high (0.7 g L(-1) h(-1)) but quickly leveled off and further study suggested this was due to product toxicity and/or acidification of the growth medium. Results also showed that endogenous thioesterases significantly influenced product formation. In particular, deletion of the yciA thioesterase gene substantially increased hexanoate production while decreasing the production of butyrate. E. coli was also engineered to co-produce enzymes for even-chain fatty acid production (described above) together with a coenzyme B12-dependent pathway for the production of propionyl-CoA which allowed the production of odd-chain fatty acids (pentanoate and heptanoate). The B12-dependent pathway used here has the potential to allow the production of odd-chain FAs from a single growth substrate (glucose) in more energy efficient manner than the prior methods.
    Full-text · Article · Apr 2014 · Microbiology
  • Source
    • "(S)-3HB biomonomer, meanwhile, can be used to produce novel PHBs with new features and properties. Prather and coworkers subsequently expanded upon their efforts to produce, for the first time, enantiomerically pure stereoisomers of the 5-carbon β-hydroxyacid 3HV (Tseng et al., 2010). This was achieved using a single renewable substrate (glucose) by first engineering E. coli to over-produce precursor propionyl-CoA via manipulation of the native L-threonine biosynthesis pathway. "
    [Show abstract] [Hide abstract]
    ABSTRACT: By applying metabolic engineering tools and strategies to engineer synthetic enzyme pathways, the number and diversity of commodity and specialty chemicals that can be derived directly from renewable feedstocks is rapidly and continually expanding. This of course includes a number of monomer building-block chemicals that can be used to produce replacements to many conventional plastic materials. This review aims to highlight numerous recent and important advancements in the microbial production of these so-called "biomonomers." Relative to naturally-occurring renewable bioplastics, biomonomers offer several important advantages, including improved control over the final polymer structure and purity, the ability to synthesize non-natural copolymers, and allowing products to be excreted from cells which ultimately streamlines downstream recovery and purification. To highlight these features, a handful of biomonomers have been selected as illustrative examples of recent works, including polyamide monomers, styrenic vinyls, hydroxyacids, and diols. Where appropriate, examples of their industrial penetration to date and end-product uses are also highlighted. Novel biomonomers such as these are ultimately paving the way toward new classes of renewable bioplastics that possess a broader diversity of properties than ever before possible.
    Preview · Article · Aug 2012 · Frontiers in Microbiology
Show more